Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

450 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Neurodegenerative disorders: Reversing Huntington's disease.

Tse MT.

Nat Rev Drug Discov. 2012 Aug;11(8):600. doi: 10.1038/nrd3804. No abstract available.

0

0

0

PUBMED

Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH.

Hum Mol Genet. 2012 Jan 15;21(2):406-20. doi: 10.1093/hmg/ddr475.

0

0

0

PUBMED

Eugenics, Heredity, and Huntington's Disease: A Brief Historical Perspective.

Wexler A.

J Huntingtons Dis. 2012;1(2):139-41. doi: 10.3233/JHD-129007. No abstract available.

0

0

0

PUBMED

A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease.

Van Camp N, Blockx I, Camón L, de Vera N, Verhoye M, Veraart J, Van Hecke W, Martínez E, Soria G, Sijbers J, Planas AM, Van der Linden A.

Neurobiol Aging. 2012 May;33(5):945-59. doi: 10.1016/j.neurobiolaging.2010.07.001.

0

0

0

PUBMED

Does Huntington's disease enhance cephalad spread during neuraxial anesthesia for cesarean section?

Draisci G, Sbaraglia F, Pinto R, Zanfini BA, Frassanito L, Catarci S.

J Clin Anesth. 2012 Sep;24(6):516-7. doi: 10.1016/j.jclinane.2011.09.011. No abstract available.

0

0

0

PUBMED

Identification and characterization of Huntington related pathology: an in vivo DKI imaging study.

Blockx I, Verhoye M, Van Audekerke J, Bergwerf I, Kane JX, Delgado Y Palacios R, Veraart J, Jeurissen B, Raber K, von Hörsten S, Ponsaerts P, Sijbers J, Leergaard TB, Van der Linden A.

Neuroimage. 2012 Nov 1;63(2):653-62. doi: 10.1016/j.neuroimage.2012.06.032.

0

0

0

PUBMED

Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Martin B, Chadwick W, Cong WN, Pantaleo N, Daimon CM, Golden EJ, Becker KG, Wood WH 3rd, Carlson OD, Egan JM, Maudsley S.

J Biol Chem. 2012 Sep 14;287(38):31766-82. doi: 10.1074/jbc.M112.387316.

0

0

0

PUBMED

Complex relationships between cerebral blood flow and brain atrophy in early Huntington's disease.

Chen JJ, Salat DH, Rosas HD.

Neuroimage. 2012 Jan 16;59(2):1043-51. doi: 10.1016/j.neuroimage.2011.08.112.

0

0

0

PUBMED

Journal of Huntington's Disease.

Leavitt BR, Thompson LM.

J Huntingtons Dis. 2012;1(1):1. doi: 10.3233/JHD-2012-120001. No abstract available.

0

0

0

PUBMED

The group 2 metabotropic glutamate receptor agonist LY379268 rescues neuronal, neurochemical and motor abnormalities in R6/2 Huntington's disease mice.

Reiner A, Lafferty DC, Wang HB, Del Mar N, Deng YP.

Neurobiol Dis. 2012 Jul;47(1):75-91. doi: 10.1016/j.nbd.2012.03.025.

0

0

0

PUBMED

Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease.

Prime ME, Brookfield FA, Courtney SM, Gaines S, Marston RW, Ichihara O, Li M, Vaidya D, Williams H, Pedret-Dunn A, Reed L, Schaertl S, Toledo-Sherman L, Beconi M, Macdonald D, Muñoz-Sanjuan I, Domingu

ACS Med Chem Lett. 2012 Aug 9;3(9):731-5. doi: 10.1021/ml3001352.

0

0

0

PUBMED

An unusually low prevalence of Huntington's disease in Iceland.

Sveinsson O, Halldórsson S, Olafsson E.

Eur Neurol. 2012;68(1):48-51. doi: 10.1159/000337680.

0

0

0

PUBMED

NP03, a novel low-dose lithium formulation, is neuroprotective in the YAC128 mouse model of Huntington disease.

Pouladi MA, Brillaud E, Xie Y, Conforti P, Graham RK, Ehrnhoefer DE, Franciosi S, Zhang W, Poucheret P, Compte E, Maurel JC, Zuccato C, Cattaneo E, Néri C, Hayden MR.

Neurobiol Dis. 2012 Dec;48(3):282-9. doi: 10.1016/j.nbd.2012.06.026.

0

0

0

PUBMED

Clinical assessment of the effect of tetrabenazine on functional scales in huntington disease: a pilot open label study.

Fekete R, Davidson A, Jankovic J.

Tremor Other Hyperkinet Mov (N Y). 2012;2. pii: tre-02-86-476-4. doi: 10.7916/D8DN43SC.

0

0

0

PUBMED

CCG polymorphisms in the huntingtin gene have no effect on the pathogenesis of patients with Huntington's disease in mainland Chinese families.

Zhang BR, Tian J, Yan YP, Yin XZ, Zhao GH, Wu ZY, Gu WH, Xia K, Tang BS.

J Neurol Sci. 2012 Jan 15;312(1-2):92-6. doi: 10.1016/j.jns.2011.08.015.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy